Cargando…

Pharmacokinetics of 10-Hydroxy Mesaconitine in Rat Plasma by Ultra-Performance Liquid Chromatography-Tandem Quadrupole Mass Spectrometry

Mesaconitine is the predominant active ingredient in Aconitum carmichaelii Debx. The compound 10-hydroxy mesaconitine is one known metabolite of mesaconitine and is toxic. In order to better understand its pharmacokinetics, UPLC-MS/MS was used in this paper to measure the concentration of 10-hydroxy...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jinzhao, Zeng, Guowu, Ma, Jianshe, Wang, Xianqin, Zhou, Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075697/
https://www.ncbi.nlm.nih.gov/pubmed/33959404
http://dx.doi.org/10.1155/2021/6640184
_version_ 1783684568949194752
author Yang, Jinzhao
Zeng, Guowu
Ma, Jianshe
Wang, Xianqin
Zhou, Quan
author_facet Yang, Jinzhao
Zeng, Guowu
Ma, Jianshe
Wang, Xianqin
Zhou, Quan
author_sort Yang, Jinzhao
collection PubMed
description Mesaconitine is the predominant active ingredient in Aconitum carmichaelii Debx. The compound 10-hydroxy mesaconitine is one known metabolite of mesaconitine and is toxic. In order to better understand its pharmacokinetics, UPLC-MS/MS was used in this paper to measure the concentration of 10-hydroxy mesaconitine in the plasma of rats after oral (5 mg/kg) and intravenous (0.1 mg/kg) administration of 10-hydroxy mesaconitine. The concentrations of 10-hydroxy mesaconitine in rat plasma measured in the standard curve covered the range of 0.3–60 ng/mL. The intraday and interday precisions of the samples of 10-hydroxy mesaconitine in rat plasma were lower than 15%. In addition, the accuracies ranged between 96.0% and 109.3%, the matrix effects ranged between 88.9% and 98.1%, and the recoveries were all higher than 79.1%. The AUC((0 − t)) values were 23.6 ± 5.9 and 207.6 ± 72.9 ng/mL·h for intravenous and oral administration, respectively, and the bioavailability of 10-hydroxy mesaconitine was 17.6%. Lastly, t(1/2) was 1.3 ± 0.6 h and 3.1 ± 0.4 h for intravenous and oral administration, respectively.
format Online
Article
Text
id pubmed-8075697
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-80756972021-05-05 Pharmacokinetics of 10-Hydroxy Mesaconitine in Rat Plasma by Ultra-Performance Liquid Chromatography-Tandem Quadrupole Mass Spectrometry Yang, Jinzhao Zeng, Guowu Ma, Jianshe Wang, Xianqin Zhou, Quan J Anal Methods Chem Research Article Mesaconitine is the predominant active ingredient in Aconitum carmichaelii Debx. The compound 10-hydroxy mesaconitine is one known metabolite of mesaconitine and is toxic. In order to better understand its pharmacokinetics, UPLC-MS/MS was used in this paper to measure the concentration of 10-hydroxy mesaconitine in the plasma of rats after oral (5 mg/kg) and intravenous (0.1 mg/kg) administration of 10-hydroxy mesaconitine. The concentrations of 10-hydroxy mesaconitine in rat plasma measured in the standard curve covered the range of 0.3–60 ng/mL. The intraday and interday precisions of the samples of 10-hydroxy mesaconitine in rat plasma were lower than 15%. In addition, the accuracies ranged between 96.0% and 109.3%, the matrix effects ranged between 88.9% and 98.1%, and the recoveries were all higher than 79.1%. The AUC((0 − t)) values were 23.6 ± 5.9 and 207.6 ± 72.9 ng/mL·h for intravenous and oral administration, respectively, and the bioavailability of 10-hydroxy mesaconitine was 17.6%. Lastly, t(1/2) was 1.3 ± 0.6 h and 3.1 ± 0.4 h for intravenous and oral administration, respectively. Hindawi 2021-04-19 /pmc/articles/PMC8075697/ /pubmed/33959404 http://dx.doi.org/10.1155/2021/6640184 Text en Copyright © 2021 Jinzhao Yang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Yang, Jinzhao
Zeng, Guowu
Ma, Jianshe
Wang, Xianqin
Zhou, Quan
Pharmacokinetics of 10-Hydroxy Mesaconitine in Rat Plasma by Ultra-Performance Liquid Chromatography-Tandem Quadrupole Mass Spectrometry
title Pharmacokinetics of 10-Hydroxy Mesaconitine in Rat Plasma by Ultra-Performance Liquid Chromatography-Tandem Quadrupole Mass Spectrometry
title_full Pharmacokinetics of 10-Hydroxy Mesaconitine in Rat Plasma by Ultra-Performance Liquid Chromatography-Tandem Quadrupole Mass Spectrometry
title_fullStr Pharmacokinetics of 10-Hydroxy Mesaconitine in Rat Plasma by Ultra-Performance Liquid Chromatography-Tandem Quadrupole Mass Spectrometry
title_full_unstemmed Pharmacokinetics of 10-Hydroxy Mesaconitine in Rat Plasma by Ultra-Performance Liquid Chromatography-Tandem Quadrupole Mass Spectrometry
title_short Pharmacokinetics of 10-Hydroxy Mesaconitine in Rat Plasma by Ultra-Performance Liquid Chromatography-Tandem Quadrupole Mass Spectrometry
title_sort pharmacokinetics of 10-hydroxy mesaconitine in rat plasma by ultra-performance liquid chromatography-tandem quadrupole mass spectrometry
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075697/
https://www.ncbi.nlm.nih.gov/pubmed/33959404
http://dx.doi.org/10.1155/2021/6640184
work_keys_str_mv AT yangjinzhao pharmacokineticsof10hydroxymesaconitineinratplasmabyultraperformanceliquidchromatographytandemquadrupolemassspectrometry
AT zengguowu pharmacokineticsof10hydroxymesaconitineinratplasmabyultraperformanceliquidchromatographytandemquadrupolemassspectrometry
AT majianshe pharmacokineticsof10hydroxymesaconitineinratplasmabyultraperformanceliquidchromatographytandemquadrupolemassspectrometry
AT wangxianqin pharmacokineticsof10hydroxymesaconitineinratplasmabyultraperformanceliquidchromatographytandemquadrupolemassspectrometry
AT zhouquan pharmacokineticsof10hydroxymesaconitineinratplasmabyultraperformanceliquidchromatographytandemquadrupolemassspectrometry